ProCE Banner Activity

2023 Global Conference Coverage Updates on BTK Inhibitors for CLL and MCL

Conference Coverage

Download this slideset, which will be updated with new data, on the use of BTK inhibitors to treat CLL and MCL from conferences throughout 2023 including EHA, ICML, SOHO, ESMO, and ASH. 

Released: July 07, 2023



Catherine C. Coombs

Catherine C. Coombs, MD, MS

Associate Clinical Professor of Medicine
Department of Medicine
Divsion of Oncology & Hematology
University of California, Irvine
Irvine, California

Toby Eyre

Toby Eyre, MBChB, MD

Honorary Senior Lecturer
Hematology and Cancer
University of Oxford
Consultant Hematologist
Department of Hematology
Hematology and Cancer Centre, Oxford University Hospitals NHS Foundation Trust
Oxford, United Kingdom

Brad Kahl

Brad Kahl, MD

Professor of Medicine
Washington University School of Medicine
Director Lymphoma Program
Siteman Cancer Center
St. Louis, Missouri 

Pier Luigi Zinzani

Pier Luigi Zinzani, MD, PhD

Professor of Hematology
Head of Lymphoma and Chronic Lymphoproliferative Syndromes Unit
Institute of Hematology “L. e A. Seràgnoli”
University of Bologna
Bologna, Italy

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


Supported by an educational grant from Lilly.